PR94512

BUDAPEST, Hungary, Feb 14, 2022, /PRNewswire=KYODO JBN/--

Chemaxon, a leader in cheminformatics software development for life science

research, announced the appointment of Richard Jones as Chief Executive Officer

(CEO). Richard follows owner Ferenc (Csizi) Csizmadia in the position.

“Chemaxon has a great reputation globally. Following on from my work in Lab of

the Future, I am excited about the opportunity to take data in science and

technology and use it to do amazing things, together with our expert team and

our expanding range of users. We have great plans for the coming years, and we

will be reaching out to our customers shortly to share them,” comments Richard

Jones, new CEO of Chemaxon.

Chemaxon’s founder and outgoing CEO, Ferenc “Csizi” Csizmadia, steps down after

almost 7 years at the helm of the company he founded 24 years ago. “We have

worked closely with Richard to align strategy and culture, in order to ensure

Chemaxon’s continued success. I have all confidence in his ability to take the

company further, and look forward to seeing the company grow and flourish under

his leadership." Csizi keeps his role as Founder and moves on to found

Ancestralize, focusing on health and well-being in the digital age.

The appointment coincides with Chemaxon Budapest offices moving to Vaci Greens,

a newly built eco-conscious office park on the eastern side of the Danube.

Chemaxon.com ( https://chemaxon.com/ )

About Chemaxon:

Chemaxon is a chemical and biochemical software company. We have developed more

than a dozen applications, including JChem Engines, Marvin, Design Hub and

more, which are widely used in universities, businesses and patent firms around

the world. Clients include Bayer, GlaxoSmithKline and Bristol-Myers Squibb. We

have offices in Budapest, Basel, Boston and San Diego and distributors around

the world.

Photo - https://mma.prnewswire.com/media/1745020/Chemaxon.jpg

Logo - https://mma.prnewswire.com/media/1745019/Chemaxon_Logo.jpg

Source: Chemaxon Kft.